🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Save the Date: March 29 at #ACC25. Join us for our moderated poster presentation and visit Booth 3041 to explore how our innovative #RNAi therapy may advance the future of #CardiovascularDisease treatment. We look forward to seeing you in Chicago! American College of Cardiology

For those with very high triglycerides, nutrition is a key part of managing levels, but maintaining the necessary restrictive diet can be taxing. Show support to this community during #NationalNutritionMonth by hearing how food impacts daily decisions: bit.ly/43muSSN

Arrowhead is proud to announce on #NationalTriglyceridesDay that we’re part of the new National Triglycerides Alliance. Together, we’ll work to ensure the treatment of high triglycerides becomes a core tenet of patient care. Learn more: bit.ly/4hRfn8K National Triglyceride Alliance

At #ACC.25 with American College of Cardiology, exploring the potential of #RNAi therapies in treating #CardiometabolicDisease. Stop by booth 3401 to learn more! #HeartHealth #Cardiology #Cardiovascular

Missed #ACC25? Explore our latest findings in JACC Journals on #hypertriglyceridemia and discover how new insights into high #triglycerides and mixed #lipid disorders have the potential to transform #hearthealth. Read more: bit.ly/42iP0Tz​ #RNAi #precisionmedicine

Save the date for our upcoming 2025 fiscal second quarter earnings call. Join our live webcast and conference call on May 12, 2025, at 4:30 PM ET to discuss the #FinancialResults. Read more in our press release: bit.ly/3Evsy1S

Heading to #EAS2025? Visit us at booth 22 to explore how #RNAi therapeutics have the potential to transform care for patients with complex #lipid disorders. We're excited to discuss how our clinical development programs are advancing #CardiometabolicCare. #Cardiology

We’re excited to participate in two upcoming fireside chats in May! Join us on May 14th for the Bank of America Securities Healthcare Conference and on May 20th for the @RBCCM Global Healthcare Conference. Read more in our press release: bit.ly/42MszHX

AT #ESPEESE2025? Visit Arrowhead at Booth E.04 to explore how #RNAi is advancing clinical development in #cardiometabolic care. We're excited to connect and share how we're driving innovation to improve patient outcomes.​​ #WeAreArrowhead #Endocrinology

Today we reported our fiscal 2025 second quarter results. Tune in to our webcast replay and read our press release to learn more: bit.ly/4iYDJOs $ARWR

Curious about the latest clinical guidance on triglycerides?​ Visit us at booth #230 at #AACE2025 in Orlando this weekend.​ We’re sharing updated recommendations for managing patients with elevated triglyceride levels and how these strategies may improve patient care.

On #ClinicalTrialsDay, we recognize the power of partnership in advancing clinical research. Thank you to the patients, caregivers, and investigators driving #RNAi -based investigational therapies forward. These trials bring us closer to meaningful treatments for rare diseases.

Are you ready to discuss all things lipids in Miami at the #NLASessions this weekend?​ Come find Andy Davis and our Arrowheads at booth #207 to learn more about the NLA Guidelines for lipid and #triglyceride management. ​ #WeAreArrowhead #ForFCS #NLA25

We’re attending two upcoming fireside chat presentations in June! Join us on June 4th at Jefferies Global Healthcare Conference & on June 9th at the Goldman Sachs 46th Annual Global Healthcare Conference. More in our press release: bit.ly/43zfJvJ #JefferiesHealthcare

What’s next in RNAi science for lipid & cardiometabolic conditions? Arrowhead is proud to have 4 abstracts accepted at the 2025 @NationalLipid Association Scientific Sessions. ​ See the agenda: bit.ly/3FsQL9u #NLASessions #RNAi #CardiometabolicHealth

Today we announced the initiation of our Phase 1/2a #ClinicalTrial of our #RNAi therapeutic as a potential treatment for #Obesity. Read more in our press release: bit.ly/4klELFM

Will you be at Heart in Diabetes 🫀 in Philadelphia? Find us to discuss how emerging science is shaping clinical guidelines for lipid disorder management and advancing #cardiometabolic care. #HeartInDiabetes

🏃Let’s go the distance to raise awareness of Familial Chylomicronemia Syndrome (FCS). Join us in walking the @LivingWIthFCS Virtual 5K on 6/11 — from anywhere. We’re a proud sponsor of the walk and will see you out there. bit.ly/4dQUEBR #FCS2025K

Today, our 4 US sites are walking the @LivingWithFCS Virtual 5K to raise awareness for Familial Chylomicronemia Syndrome—a rare disease affecting as few as 1 in a million. 💙 We walk to fight for patients & families. Share your story: bit.ly/4jPshoS #FCS2025k

Today we announced we completed enrollment for studies in our Phase 3 #ClinicalTrials designed to support regulatory submissions for marketing approval for the treatment of severe hypertriglyceridemia. Read more in our press release: bit.ly/4k6WDn9